[Medical risk assessment in life insurance of applicants following coronary angioplasty].
The high incidence of instant results of PTCA in patients with coronary artery disease and the favourable prognosis of long-term follow-ups are beneficial for proposers being accepted for life insurance, even though they belonged to the group of high-risk-patients before. In assessing life insurance policies it is necessary to take the individual course of the CAD, the PTCA itself and the remaining left ventricular function into consideration. Risk factors and other cardiac or non-cardiac impairments must be regarded additionally.
Genser
N
N
Gerling-Konzern Globale Rückversicherungs-AG.
D015906:Angioplasty, Balloon, Coronary / Q000401:mortality*; D003327:Coronary Disease / Q000401:mortality* / Q000628:therapy; D005858:Germany; D006801:Humans; D007352:Insurance, Life / Q000706:statistics & numerical data*; D008017:Life Expectancy; D012008:Recurrence; D012307:Risk Factors; D015996:Survival Rate
Medizinische Risikoeinschätzung in der Lebensversicherung bei Antragstellern nach Koronarangioplastie.